T1 Protein 125 139 angiopoietin-2
T2 Protein 733 746 blood vessels
T4 Condition 546 551 tumor
T5 Condition 1244 1250 cancer
T7 Condition 243 248 tumor
T8 Protein 333 336 A2V
T10 Intervention 974 982 vascular
T11 Protein 1131 1135 IFNγ
T12 Condition 482 507 metastatic breast cancer 
T13 Condition 43 49 cancer
T14 Protein 929 932 A2V
T15 Protein 596 599 A2V
T16 Gene 825 838 interferon-γ 
T17 Condition 1210 1215 tumor
T18 Protein 163 167 ANG2
T19 Protein 281 287 ANGPT2
T20 Biomarker 1096 1101 PD-L1
T21 Intervention 970 982 perivascular
T22 Protein 839 843 IFNγ
T23 Gene_or_gene_product 1039 1094 immune checkpoint ligand programmed cell death ligand 1
T24 Intervention 785 797 perivascular
T25 Level 1106 1129 tumor endothelial cells
T26 Gene 420 431 genetically
T27 Level 1265 1295 findings position immune cells
T28 Condition 500 506 cancer
T29 Condition 679 684 tumor
T30 Protein 292 297 VEGFA
T31 Condition 210 215 tumor
T32 Protein 141 147 ANGPT2
T33 Protein 1227 1230 A2V
T34 CL 674 697 intratumoral phagocytes
T35 Condition 905 916 antitumoral
T36 Condition 239 248 antitumor
T37 Condition 1106 1111 tumor
T39 Protein 1303 1312 effectors
T40 Condition 630 635 tumor
T41 Biomarker 1187 1191 PD-1
T42 Protein 114 119 VEGFA
T43 Condition 630 644 tumor necrosis
T44 Condition 1420 1426 cancer
T45 Gene 312 331 bispecific antibody
T46 Condition 447 463 transplant tumor
T47 Intervention 609 617 vascular
T49 Gene 76 112 Vascular endothelial growth factor A
T50 Condition 905 914 antitumor
R1 Relation Arg1:T18 Arg2:T31
R2 Relation Arg1:T42 Arg2:T18
R3 Relation Arg1:T42 Arg2:T31
